Biotechnology research and development.

Producer of sustainable pet foods designed to serve dogs and cats. The company’s technology specializes in developing clean protein pet foods that are healthier, better for the environment, and more humane than conventional products, enabling pets to get all their nutritional needs and stay healthy.

The vision of Vicinitas Therapeutics is to become the leading company developing next-generation medicines that impact patient lives. Their vision is to use our proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Via Nova Therapeutics deploys state-of-the-art drug discovery modalities to identify novel, first-in-class antivirals for the individual infections they study. These modalities include phenotypic screening in infected cultured cells, biochemical screening in vitro on virus-encoded enzymatic targets and structure-based drug design, as well as combinations of the above approaches. 

Brings the power of genomics and gene editing to agriculture by developing collaborative relationships with breeders and researchers. By integrating genomic resources with a deep understanding of market demands, they develop novel crop varieties that increase productivity, resist disease, and answer consumer demands.

Developer of new generation drugs designed to improve the current treatment strategies for a variety of diseases. The company’s drugs act within a targeted diseased tissue and modify therapeutic proteins to achieve substantial control over pharmacokinetics, enabling physicians to treat their patients in an enhanced way.

Provider of big data services intended to facilitate genomics discovery. The company’s services specializes in harnessing the power of full genome sequencing and scalable computing using machine learning for large-scale genomic analyses, enabling biopharmaceutical and clinical research industries to inform and shape clinical trials.